Guiyang Xintian Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Guiyang Xintian Pharmaceutical Co Ltd cash flow-to-debt ratio. Guiyang Xintian Pharmaceutical Co Ltd (002873) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥48.81 Million could theoretically repay 0% of its total liabilities (CN¥829.62 Million) in one year. Check how high is Guiyang Xintian Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
Cash flow-to-debt ratio of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. Historical debt coverage capacity for Guiyang Xintian Pharmaceutical Co Ltd across 14 annual periods. Check Guiyang Xintian Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Guiyang Xintian Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Guiyang Xintian Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Guiyang Xintian Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guiyang Xintian Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥83.73 Million | CN¥864.83 Million | ▼ -17.0% |
| 2024 | 0.12x | CN¥88.13 Million | CN¥755.79 Million | ▲ +19.7% |
| 2023 | 0.10x | CN¥77.78 Million | CN¥798.47 Million | ▼ -8.2% |
| 2022 | 0.11x | CN¥75.82 Million | CN¥714.65 Million | ▼ -45.9% |
| 2021 | 0.20x | CN¥124.30 Million | CN¥633.98 Million | ▼ -21.1% |
| 2020 | 0.25x | CN¥175.77 Million | CN¥707.64 Million | ▲ +176.1% |
| 2019 | 0.09x | CN¥33.73 Million | CN¥374.89 Million | ▼ -38.8% |
| 2018 | 0.15x | CN¥47.59 Million | CN¥323.72 Million | ▼ -44.5% |
| 2017 | 0.26x | CN¥62.06 Million | CN¥234.30 Million | ▲ +16.7% |
| 2016 | 0.23x | CN¥61.34 Million | CN¥270.33 Million | ▲ +52.1% |
| 2015 | 0.15x | CN¥40.73 Million | CN¥273.05 Million | ▲ +10.9% |
| 2014 | 0.13x | CN¥37.30 Million | CN¥277.26 Million | ▲ +115.6% |
| 2013 | 0.06x | CN¥13.88 Million | CN¥222.36 Million | ▼ -53.8% |
| 2012 | 0.14x | CN¥21.41 Million | CN¥158.40 Million | — |